DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,487 filers reported holding DANAHER CORPORATION in Q1 2020. The put-call ratio across all filers is 1.05 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,495 | +70.9% | 6,026 | +65.2% | 0.13% | +68.8% |
| Q2 2023 | $875 | +88.6% | 3,647 | +98.1% | 0.08% | +108.1% |
| Q1 2023 | $464 | +0.9% | 1,841 | +6.2% | 0.04% | -14.0% |
| Q4 2022 | $460 | -99.9% | 1,733 | -5.6% | 0.04% | -6.5% |
| Q3 2022 | $474,000 | +8.7% | 1,835 | +6.7% | 0.05% | +7.0% |
| Q2 2022 | $436,000 | -27.2% | 1,720 | -15.8% | 0.04% | -8.5% |
| Q1 2022 | $599,000 | -25.3% | 2,042 | -16.3% | 0.05% | -23.0% |
| Q4 2021 | $802,000 | +10.6% | 2,439 | +2.4% | 0.06% | 0.0% |
| Q3 2021 | $725,000 | +13.5% | 2,382 | 0.0% | 0.06% | +13.0% |
| Q2 2021 | $639,000 | +28.6% | 2,382 | +7.8% | 0.05% | +10.2% |
| Q1 2021 | $497,000 | +2.7% | 2,209 | +1.4% | 0.05% | -3.9% |
| Q4 2020 | $484,000 | -1.2% | 2,179 | -4.2% | 0.05% | -25.0% |
| Q3 2020 | $490,000 | +48.5% | 2,274 | +21.8% | 0.07% | +38.8% |
| Q2 2020 | $330,000 | +26.4% | 1,867 | -1.1% | 0.05% | -5.8% |
| Q1 2020 | $261,000 | -20.7% | 1,888 | -12.0% | 0.05% | +13.0% |
| Q4 2019 | $329,000 | +3.1% | 2,146 | -2.8% | 0.05% | -8.0% |
| Q3 2019 | $319,000 | -19.8% | 2,208 | -20.8% | 0.05% | -20.6% |
| Q2 2019 | $398,000 | -84.8% | 2,787 | +705.5% | 0.06% | +320.0% |
| Q1 2019 | $2,621,000 | +87266.7% | 346 | +28.1% | 0.02% | -31.8% |
| Q4 2018 | $3,000 | -98.9% | 270 | +8900.0% | 0.02% | -56.9% |
| Q3 2018 | $285,000 | -4.7% | 3 | -99.9% | 0.05% | +24.4% |
| Q2 2018 | $299,000 | +21.5% | 3,026 | +20.3% | 0.04% | -29.3% |
| Q1 2018 | $246,000 | – | 2,516 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |